The expression of ALKBH5 and FTO has been proved to be up-regulated in tumor tissues, which implies a poor prognosis of HCC patients (Li et al., 2019; Qu et al., 2021). This evidence concerns the gene ALKBH5 and hepatocellular carcinoma.